We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
-15.2%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.18B
AUM Growth
-$173M
Cap. Flow
+$50M
Cap. Flow %
4.25%
Top 10 Hldgs %
31.89%
Holding
2,429
New
979
Increased
279
Reduced
240
Closed
895

Sector Composition

Rank Sector Weight
1 Technology 14.05%
2 Healthcare 13.79%
3 Financials 8.37%
4 Communication Services 8.09%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDC
1101
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$55K ﹤0.01%
+53,006
New +$85.8K
CIA icon
1102
Citizens
CIA
$199M
$54K ﹤0.01%
+12,918
New +$46.6K
OGI
1103
Organigram Holdings
OGI
$180M
$54K ﹤0.01%
+14,792
New +$75.4K
SENS icon
1104
Senseonics Holdings Inc
SENS
$408M
$54K ﹤0.01%
2,612
-5,422
-67% -$141K
TKAT
1105
DELISTED
Takung Art Co., Ltd.
TKAT
$54K ﹤0.01%
32,567
-4,466
-12% -$10.1K
OTIC
1106
DELISTED
Otonomy, Inc.
OTIC
$54K ﹤0.01%
26,111
+12,059
+86% +$25.1K
DBGI
1107
Digital Brands Group
DBGI
$10.1M
0
ZNB
1108
Zeta Network Group
ZNB
$2.55M
0
CRESY
1109
Cresud
CRESY
$757M
$53K ﹤0.01%
+10,853
New +$72.3K
INZY
1110
DELISTED
Inozyme Pharma
INZY
$53K ﹤0.01%
+11,179
New +$48.6K
NCZ
1111
Virtus Convertible & Income Fund II
NCZ
$307M
$53K ﹤0.01%
+4,215
New +$60.9K
SCPH
1112
DELISTED
scPharmaceuticals
SCPH
$53K ﹤0.01%
+10,999
New +$54.4K
MOR
1113
DELISTED
MorphoSys AG American Depositary Shares
MOR
$53K ﹤0.01%
+11,050
New +$61K
CANF
1114
Can-Fite BioPharma American Depositary Shares
CANF
$7.39M
$52K ﹤0.01%
+282
New +$54.1K
CYH icon
1115
Community Health Systems
CYH
$403M
$52K ﹤0.01%
+13,900
New +$97.9K
ONCO icon
1116
Onconetix
ONCO
$3.31M
0
SBFM
1117
Sunshine Biopharma
SBFM
$2.88M
$52K ﹤0.01%
2
+1
+100% +$48.8K
TGTX icon
1118
TG Therapeutics
TGTX
$7.71B
$52K ﹤0.01%
12,191
-8,374
-41% -$52.3K
WGS icon
1119
GeneDx Holdings
WGS
$2.46B
$52K ﹤0.01%
1,250
+802
+179% +$54.4K
THMO
1120
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$52K ﹤0.01%
+4,215
New +$83.1K
TTOO
1121
DELISTED
T2 Biosystems, Inc
TTOO
$52K ﹤0.01%
65
+62
+2,067% +$91.9K
CRGE
1122
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$52K ﹤0.01%
+10,817
New +$55.8K
QUOT
1123
DELISTED
Quotient Technology Inc
QUOT
$52K ﹤0.01%
+17,492
New +$83K
CKPT
1124
DELISTED
Checkpoint Therapeutics
CKPT
$51K ﹤0.01%
+4,978
New +$65.2K
CNSP icon
1125
CNS Pharmaceuticals
CNSP
$7.67M
0

Similar funds

Virtu Financial's Q2 2022 Portfolio in Review

As of Q2 2022, Virtu Financial held 2,429 positions worth $1.18B, down 13% from $1.35B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Virtu Financial deployed $50M of net new capital in Q2 2022, opening 979 new positions and adding to 279 existing holdings. Its largest new stake was CMC Materials, Inc. Common Stock: 361,092 shares worth $63M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $258M trimmed.

  • Virtu Financial's largest Q2 2022 buy was CMC Materials, Inc. Common Stock: 361,092 shares worth $63M.
  • Virtu Financial added most to Coherent Inc in Q2 2022, an estimated $62.2M increase.
  • Virtu Financial's biggest Q2 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $258M.
  • Virtu Financial fully exited People's United Financial Inc in Q2 2022, selling an estimated $105M.
  • Virtu Financial's ten largest holdings make up 32% of its $1.18B portfolio in Q2 2022.
  • Virtu Financial opened 979 new positions and closed 895 in Q2 2022.
  • Virtu Financial's portfolio value fell 13% quarter-over-quarter to $1.18B.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.